SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001388410-18-000073
Filing Date
2018-11-15
Accepted
2018-11-14 21:58:03
Documents
6
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT 20180930prlxform10qinline.htm 10-Q 961574
2 EX 31.1 SEC 302 CERTIFICATION-CEO ex311sect302certceo.htm EX-31 7741
3 EX 31.2 SEC 302 CERTIFICATION-CFO ex312sect302certcfo.htm EX-31 7749
4 EX 32.1 SEC 906 CERTIFICATION-CEO ex321sect906certceo.htm EX-32 4351
5 EX 32.2 SEC 906 CERTIFICATION-CFO ex322sect906certcfo.htm EX-32 4511
6 IMAGE f20180930prlxform10qinline_1.jpg GRAPHIC 58416
  Complete submission text file 0001388410-18-000073.txt   1067838
Mailing Address 1327 OCEAN AVENUE, SUITE M SANTA MONICA CA 90401
Business Address 1327 OCEAN AVENUE, SUITE M SANTA MONICA CA 90401 310-899-4442
PARALLAX HEALTH SCIENCES, INC. (Filer) CIK: 0001388410 (see all company filings)

IRS No.: 464733512 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52534 | Film No.: 181185861
SIC: 5912 Retail-Drug Stores and Proprietary Stores
Assistant Director 9